Breathing Problems Self Assessment Questionnaire If you are having breathing difficulties, complete this questionnaire. If some or all of these signs and symptoms of emphysema, chronic bronchitis, and COPD fit you, please print the questionnaire. Take it to your doctor as soon as possible. The earlier COPD is diagnosed, the more effective treatment will be. Do you experience severe shortness of breath when you exercise or climb the stairs?  Yes  No Do you have a persistent cough that has lasted for more than a month?  Yes  No Have you noticed an increase in sputum production, thicker sputum, or a change in sputum color?  Yes  No Do you have risk factors like smoking or family members with COPD?  Yes  No Do you have problems sleeping? Do you sleep better while sitting up?  Yes  No Have you had an unexplained increase or decrease in weight?  Yes  No Do you feel more tired and have less energy than usual?  Yes  No Printer-Friendly Page
© 2007 Dey, L.P. SAFETY INFORMATION   .   PATIENT PRESCRIBING INFORMATION   .   FULL PRESCRIBING INFORMATION PRIVACY POLICY   .   CONTACT US   .   REFERENCES   .   SITE MAP Please read this important safety information about DuoNeb® DuoNeb® is indicated for the treatment of bronchospasm associated with COPD for patients requiring more than one bronchodilator. In a 12-week clinical study, the most common adverse reactions reported with DuoNeb® Inhalation Solution were chest pain, pharyngitis, diarrhea, bronchitis, nausea, and leg cramps. Albuterol sulfate can have a significant cardiovascular effect, significant hypokalemia, and the potential life-threatening paradoxical bronchospasm. Caution is advised in patients with convulsive disorders, hyperthyroidism, diabetes mellitus, narrow-angle glaucoma, prostatic hypertrophy, or bladder-neck obstruction. Co-administration of DuoNeb® Inhalation Solution and other sympathomimetic agents may increase the risk of adverse cardiovascular effects.